Using quantitative real-time polymerase chain reaction, the authors found that while the mRNA for the full-length CAPON protein was unchanged in either disorder, for both schizophrenia and bipolar disorder, mRNA expression of the novel shortened CAPON isoform was increased compared to the psychiatrically normal controls. This evidence concerns the gene NOS1AP and schizophrenia.